LEADER 01725nam  2200529 a 450 
001 9910452898903321
005 20200520144314.0
010   $a1-61470-776-6
035   $a(CKB)2550000001042793
035   $a(EBL)3020574
035   $a(SSID)ssj0000875076
035   $a(PQKBManifestationID)12446034
035   $a(PQKBTitleCode)TC0000875076
035   $a(PQKBWorkID)10887777
035   $a(PQKB)10036624
035   $a(MiAaPQ)EBC3020574
035   $a(Au-PeEL)EBL3020574
035   $a(CaPaEBR)ebr10677965
035   $a(OCoLC)835160909
035   $a(EXLCZ)992550000001042793
100   $a20110610d2012      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aHepatocellular carcinoma$b[electronic resource] $ea global challenge /$fIsabelle Chemin, editor
210   $aNew York $cNova Biomedical/Nova Science Publishers$dc2012
215   $a1 online resource (238 p.)
225 1 $aCancer etiology, diagnosis and treatments
300   $aDescription based upon print version of record.
311   $a1-61470-644-1 
320   $aIncludes bibliographical references and index.
327   $asection 1. Epidemiology of hepatocellular carcinoma -- section 2. Promising new biomarkers for hepatocellular carcinoma.
410  0$aCancer etiology, diagnosis, and treatments.
606   $aLiver$xCancer
608   $aElectronic books.
615  0$aLiver$xCancer.
676   $a616.99/436
701   $aChemin$b Isabelle$f1965-$0884059
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910452898903321
996   $aHepatocellular carcinoma$91974235
997   $aUNINA